140 related articles for article (PubMed ID: 37001741)
1. Modified MRC assessment and FEV1.0 can predict frequent acute exacerbation of COPD: An observational prospective cohort study at a single-center in Japan.
Asai N; Ohkuni Y; Ohashi W; Kaneko N
Respir Med; 2023 Jun; 212():107218. PubMed ID: 37001741
[TBL] [Abstract][Full Text] [Related]
2. The Ability of Different Scoring Systems to Predict Mortality in Chronic Obstructive Pulmonary Disease Patients: A Prospective Cohort Study.
Kim J; Lee CH; Hwang SS; Kim DK; Yoon HI; Lee SH; Kim KU; Kim EK; Kim TH; Lee JH; Oh YM; Lee SD
Respiration; 2019; 98(6):495-502. PubMed ID: 31665736
[TBL] [Abstract][Full Text] [Related]
3. Relationship between the presence of bronchiectasis and acute exacerbation in Thai COPD patients.
Kawamatawong T; Onnipa J; Suwatanapongched T
Int J Chron Obstruct Pulmon Dis; 2018; 13():761-769. PubMed ID: 29535516
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the Modified Medical Research Council Dyspnea Scale for Predicting Hospitalization and Exacerbation in Japanese Patients with Chronic Obstructive Pulmonary Disease.
Natori H; Kawayama T; Suetomo M; Kinoshita T; Matsuoka M; Matsunaga K; Okamoto M; Hoshino T
Intern Med; 2016; 55(1):15-24. PubMed ID: 26726080
[TBL] [Abstract][Full Text] [Related]
5. Modified Medical Research Council scale vs Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary disease.
Perez T; Burgel PR; Paillasseur JL; Caillaud D; Deslée G; Chanez P; Roche N;
Int J Chron Obstruct Pulmon Dis; 2015; 10():1663-72. PubMed ID: 26316740
[TBL] [Abstract][Full Text] [Related]
6. Malnutrition, Airflow Limitation and Severe Emphysema are Risks for Exacerbation of Chronic Obstructive Pulmonary Disease in Japanese Subjects: A Retrospective Single-Center Study.
Yamaya M; Usami O; Nakayama S; Tode N; Yamada A; Ito S; Omata F; Momma H; Funakubo M; Ichinose M
Int J Chron Obstruct Pulmon Dis; 2020; 15():857-868. PubMed ID: 32368031
[TBL] [Abstract][Full Text] [Related]
7. GOLD Classification of COPD: Discordance in Criteria for Symptoms and Exacerbation Risk Assessment.
Mittal R; Chhabra SK
COPD; 2017 Feb; 14(1):1-6. PubMed ID: 27723367
[TBL] [Abstract][Full Text] [Related]
8. GOLD assessment of COPD severity in the Clinical Practice Research Datalink (CPRD).
Rebordosa C; Plana E; Aguado J; Thomas S; García-Gil E; Perez-Gutthann S; Castellsague J
Pharmacoepidemiol Drug Saf; 2019 Feb; 28(2):126-133. PubMed ID: 29740896
[TBL] [Abstract][Full Text] [Related]
9. Application of the new GOLD COPD staging system to a US primary care cohort, with comparison to physician and patient impressions of severity.
Mapel DW; Dalal AA; Johnson PT; Becker LK; Hunter AG
Int J Chron Obstruct Pulmon Dis; 2015; 10():1477-86. PubMed ID: 26251587
[TBL] [Abstract][Full Text] [Related]
10. Management Reality of Female Patients with COPD: A Multicenter Cross-Sectional CAP Study in Japan.
Yamamoto T; Oishi K; Ohata S; Murata Y; Yamaji Y; Asami-Noyama M; Edakuni N; Kakugawa T; Hirano T; Matsunaga K
Int J Chron Obstruct Pulmon Dis; 2024; 19():1123-1130. PubMed ID: 38803411
[TBL] [Abstract][Full Text] [Related]
11. Impact of using the new GOLD classification on the distribution of COPD severity in clinical practice.
Hernández M; García G; Falco J; García AR; Martín V; Ibarrola M; Quadrelli S
Int J Chron Obstruct Pulmon Dis; 2018; 13():351-356. PubMed ID: 29403272
[TBL] [Abstract][Full Text] [Related]
12. Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort.
Han MK; Quibrera PM; Carretta EE; Barr RG; Bleecker ER; Bowler RP; Cooper CB; Comellas A; Couper DJ; Curtis JL; Criner G; Dransfield MT; Hansel NN; Hoffman EA; Kanner RE; Krishnan JA; Martinez CH; Pirozzi CB; O'Neal WK; Rennard S; Tashkin DP; Wedzicha JA; Woodruff P; Paine R; Martinez FJ;
Lancet Respir Med; 2017 Aug; 5(8):619-626. PubMed ID: 28668356
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of a COPD population categorised using the GOLD framework by health status and exacerbations.
Jones PW; Nadeau G; Small M; Adamek L
Respir Med; 2014 Jan; 108(1):129-35. PubMed ID: 24041746
[TBL] [Abstract][Full Text] [Related]
14. GOLD 2011 disease severity classification in COPDGene: a prospective cohort study.
Han MK; Muellerova H; Curran-Everett D; Dransfield MT; Washko GR; Regan EA; Bowler RP; Beaty TH; Hokanson JE; Lynch DA; Jones PW; Anzueto A; Martinez FJ; Crapo JD; Silverman EK; Make BJ
Lancet Respir Med; 2013 Mar; 1(1):43-50. PubMed ID: 24321803
[TBL] [Abstract][Full Text] [Related]
15. The effect of comorbidities on COPD assessment: a pilot study.
Weinreich UM; Thomsen LP; Bielaska B; Jensen VH; Vuust M; Rees SE
Int J Chron Obstruct Pulmon Dis; 2015; 10():429-38. PubMed ID: 25750525
[TBL] [Abstract][Full Text] [Related]
16. Determinants of Clinical COPD Questionnaire in Patients with COPD: A Cross-Sectional Observational Study.
Zhou Z; Zhou A; Peng Y; Duan J; Zeng Y; Zhao Y; Cheng W; Chen P
Respiration; 2020; 99(7):606-616. PubMed ID: 32659763
[TBL] [Abstract][Full Text] [Related]
17. Impact of symptom variability on clinical outcomes in COPD: analysis of a longitudinal cohort.
Kim MA; Suh MK; Park J; Kim JH; Kim TH; Kim EK; Oh YM; Lee SD; Lee JH
Int J Chron Obstruct Pulmon Dis; 2019; 14():2135-2144. PubMed ID: 31571850
[TBL] [Abstract][Full Text] [Related]
18. The Relationship Between Clinical Phenotypes and Global Initiative for Chronic Obstructive Lung Disease (GOLD) Stages/Groups in Patients With Chronic Obstructive Pulmonary Disease.
Pandey AK; Verma AK; Singh A; Kant S; Dixit RK; Chaudhary SC; Bajpai J; Prakash V; Verma UP
Cureus; 2022 Dec; 14(12):e32116. PubMed ID: 36601200
[TBL] [Abstract][Full Text] [Related]
19. [Risk assessment of intensive care unit admission for postoperative patients with stable chronic obstructive pulmonary disease].
Fan J; Zhao L
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Oct; 33(10):1209-1214. PubMed ID: 34955130
[TBL] [Abstract][Full Text] [Related]
20. Prognostic assessment in COPD without lung function: the B-AE-D indices.
Boeck L; Soriano JB; Brusse-Keizer M; Blasi F; Kostikas K; Boersma W; Milenkovic B; Louis R; Lacoma A; Djamin R; Aerts J; Torres A; Rohde G; Welte T; Martinez-Camblor P; Rakic J; Scherr A; Koller M; van der Palen J; Marin JM; Alfageme I; Almagro P; Casanova C; Esteban C; Soler-Cataluña JJ; de-Torres JP; Miravitlles M; Celli BR; Tamm M; Stolz D
Eur Respir J; 2016 Jun; 47(6):1635-44. PubMed ID: 27103389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
